Click on the interactive chart below to see sales data over time.
2. Allergan Inc. ( AGN): Operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. Market cap at $27.19B, most recent closing price at $94.80. Gross profit margins increased from 83.33% to 85.32% during the first time interval (12 months ending 2010-12-31 vs. 12 months ending 2009-12-31). For the second time interval, gross margins increased from 85.32% to 86.18% (12 months ending 2011-12-31 vs. 12 months ending 2010-12-31). And for the final time interval, gross margins increased from 86.18% to 86.7% (12 months ending 2012-12-31 vs. 12 months ending 2011-12-31). Allergan's FDA-approved products include ALPHAGAN, COMBIGAN, and LUNIGAN for glaucoma and other eye conditions as well as BOTOX for overactive bladder, migraines, and several other medical conditions.
3. Bristol-Myers Squibb Company ( BMY): Develops, and delivers innovative medicines that help patients prevail over serious diseases. Market cap at $86.48B, most recent closing price at $51.86.